How Much Weight Can You Lose on Wegovy in 3 Months?

Free clinical consultation (no up-front charge to find out whether you're suitable
Same-day review by a GPhC-registered Independent Prescriber, every time
Free next-working-day DPD delivery, tracked and dispatched in plain packaging
Priority aftercare seven days a week and clinical re-review before every repeat) no auto-renewals

In the first three months on Wegovy, most people are still working through the dose-escalation phase rather than sitting at the full maintenance dose, so weight loss during this window tends to be more gradual than the headline trial figures suggest. Clinical trial data published in the NEJM STEP 1 study showed an average of around 15% body-weight reduction over 68 weeks at the 2.4 mg maintenance dose — the three-month mark lands well before most participants reached that dose. Real-world figures for the first twelve weeks are typically in the 4–8% range, though individual results vary considerably depending on starting weight, dose reached, lifestyle changes and how your body responds. Wegovy (semaglutide) is a prescription-only medicine: a prescriber reviews your full picture before treatment starts, and a personalised plan matters far more than a number you read online.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the first three months on Wegovy actually look like, and how cost fits in

Step 1: The escalation phase — why the first 12 weeks are slower than the headline numbers

Wegovy's dose schedule exists to protect your digestive system, not to limit results. Treatment starts at 0.25 mg weekly, stepping up through 0.5 mg, then 1.0 mg, then 1.7 mg, before reaching the 2.4 mg maintenance dose, each step roughly four weeks apart. That means most people spend almost the entire first three months below the dose at which the large-scale trial results were measured.

This is worth understanding before you compare your week-eight experience to a friend who has been on treatment for a year. Appetite suppression does build progressively, and most people notice meaningful changes in hunger and portion size well before they reach the top dose. If you are curious about how much weight loss to expect in the first three months on Wegovy, our dedicated page covers what the evidence shows during the escalation phase specifically. Weight loss in this phase is real; it is simply steadier than the figures that tend to circulate online. If you are thinking about what results might look like over a longer stretch, our page on weight loss on Wegovy at six months covers what the evidence shows once the maintenance dose is established.

One thing our prescribers hear regularly: people feel slightly deflated at week eight when the scales haven't moved as dramatically as they hoped. That reaction is understandable. It does not mean the treatment is failing.

Step 2: What private Wegovy actually costs, and what the headline price may not include

Private Wegovy pricing in the UK is quoted per pen, per month, and varies between providers and dose levels. Since Eli Lilly's list-price increase for tirzepatide in September 2025, the broader private GLP-1 market has seen upward price pressure across the board, and semaglutide pricing has followed. For a realistic picture of what Wegovy costs month by month, our dedicated Wegovy price guide sets out the current market context without the confusion of small print.

What matters more than the headline figure is what that price actually covers. Some providers quote a per-pen cost that excludes the consultation, the prescription fee, delivery and any ongoing clinical support. Each of those adds up. A quoted price that looks lower than a competitor's may simply be less complete. Asking "what does this price include?" before committing is sensible consumer behaviour, not cynicism. More about how nume works is on our about page if you want to understand the service before you start.

Step 3: Where nume sits on price, and why we say so plainly

We are not the cheapest option in the market. That is a deliberate choice. One transparent price at nume covers the consultation, the prescription, the medicine, tracked next-working-day DPD delivery and seven-day aftercare, nothing added at checkout. There are no subscriptions and no auto-renewals; every repeat order is reviewed afresh by a named prescriber before anything is dispatched.

The clinical review piece matters particularly in the context of a weight-loss medicine. Wegovy is a prescription-only medicine, regulated as such by the MHRA, and the NICE appraisal for semaglutide (TA875) is explicit that monitoring and clinical oversight are part of appropriate use. A service that charges less by skipping genuine review is not cheaper in any meaningful sense, it is just less safe. Our clinical team personally reviews every consultation; that is not a marketing line but a description of how the service is structured.

Step 4: Why cheapest is the wrong test for a prescription medicine

When you are buying a GLP-1 medicine online, the MHRA's guidance is unambiguous: only obtain these medicines with a valid prescription from a pharmacy you can verify. The GPhC register at registration number 9012878 confirms nume's pharmacy status, that link takes you directly to our entry. Sellers offering these medicines without clinical assessment, or at prices that sit well below the licensed supply chain, are a red flag the regulator has flagged publicly on multiple occasions.

For a prescription medicine, the useful question is not "who is cheapest?" but "is this genuinely supervised, genuinely from the licensed supply chain, and genuinely reviewed by a real clinician?" Those things cost something. They are also what keep treatment safe. For anyone weighing up how much weight you can realistically lose on Wegovy, our overview pulls together what the clinical evidence actually says, across different timeframes and doses. And if the monthly picture is what you are working through, our page on monthly results covers that specifically, though if you want to understand the overall ceiling of what Wegovy can achieve, our guide on total weight loss with Wegovy brings together what the evidence shows across the full course of treatment.

Starting is straightforward. A free consultation takes a few minutes; a real prescriber reads your answers the same day; if you are clinically suitable and order before noon, treatment is dispatched that afternoon and with you the next working day. Start your free consultation when you are ready.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions